Dr. Spitzer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
444 S San Vicente Blvd
Suite 603
Los Angeles, CA 90048Phone+1 310-423-9211Fax+1 310-665-7256
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Orthopaedic Surgery, 1992 - 1993
- University of Pennsylvania Health SystemResidency, Orthopaedic Surgery, 1987 - 1992
- David Geffen School of Medicine at UCLAClass of 1987
Certifications & Licensure
- CA State Medical License 1992 - 2026
- MA State Medical License 1992 - 2011
- PA State Medical License 1990 - 2008
- American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
Publications & Presentations
PubMed
- Improved Pain and Function With Triamcinolone Acetonide Extended-Release and Cryoneurolysis for Knee Osteoarthritis: Use of a New Real-World Registry.Michael A Mont, Jennifer H Lin, Andrew I Spitzer, Vinod Dasa, Adam Rivadeneyra
The Journal of Arthroplasty. 2025-02-01 - Cryoneurolysis Associated With Improved Pain, Function, and Sleep in Patients Following total Knee Arthroplasty: Use of a New Real-World Registry.Michael A Mont, Jennifer H Lin, Andrew I Spitzer, Vinod Dasa, Adam Rivadeneyra
The Journal of Arthroplasty. 2025-01-01 - Extended-Release Versus Immediate-Release Triamcinolone Acetonide in Patients Who Have Knee Osteoarthritis and Type 2 Diabetes Mellitus.Andrew I Spitzer, Helena W Rodbard, Sheikh Usman Iqbal, Masato Nakazawa, Mary DiGiorgi
The Journal of Arthroplasty. 2024-09-01
Press Mentions
- Flexion Therapeutics Announces Upcoming Presentations at the 2019 Osteoarthritis Research Society International (OARSI) World CongressMay 2nd, 2019
- Flexion Therapeutics Announces Publication of Data from Repeat Administration Trial of ZILRETTA® (Triamcinolone Acetonide Extended-Release Injectable Suspension) in Rheumatology and TherapyFebruary 11th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: